Coherus Oncology, Inc. short interest in 2025
In 2025, Coherus Oncology, Inc.'s disclosed short interest ran from 25.86% of shares outstanding on 15 Jan 2025 to 24.05% on 31 Dec 2025, a change of -1.81 percentage points. The year's high was 28.67% on 15 Apr 2025 and its low 24.05% on 31 Dec 2025, averaging 26.87% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 38.11 days on 31 Dec 2025. Full history: Coherus Oncology, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 25.86% (15 Jan 2025)
- End of year
- 24.05% (31 Dec 2025)
- Change
- -1.81 pp
- High
- 28.67% (15 Apr 2025)
- Low
- 24.05% (31 Dec 2025)
- Average
- 26.87%
- Highest days to cover
- 38.11 (31 Dec 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 25.86% | 16.08 | results (8-K) |
| 31 Jan 2025 | 26.82% | 10.29 | |
| 14 Feb 2025 | 27.61% | 26.61 | |
| 28 Feb 2025 | 26.71% | 23.69 | |
| 14 Mar 2025 | 28.26% | 14.55 | results (8-K) |
| 31 Mar 2025 | 28.20% | 16.16 | 10-K filed |
| 15 Apr 2025 | 28.67% | 16.57 | |
| 30 Apr 2025 | 28.09% | 19.05 | |
| 15 May 2025 | 28.57% | 17.70 | 10-Q filed, results (8-K) |
| 30 May 2025 | 28.06% | 30.12 | |
| 13 Jun 2025 | 27.55% | 24.46 | |
| 30 Jun 2025 | 27.55% | 24.20 | |
| 15 Jul 2025 | 26.94% | 23.08 | |
| 31 Jul 2025 | 27.82% | 23.38 | |
| 15 Aug 2025 | 28.16% | 23.86 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 27.47% | 23.69 | |
| 15 Sep 2025 | 27.42% | 27.18 | |
| 30 Sep 2025 | 26.79% | 19.93 | |
| 15 Oct 2025 | 25.95% | 28.00 | |
| 31 Oct 2025 | 24.90% | 33.32 | |
| 14 Nov 2025 | 24.14% | 16.77 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 24.52% | 28.21 | |
| 15 Dec 2025 | 24.70% | 29.33 | |
| 31 Dec 2025 | 24.05% | 38.11 |
See also: Coherus Oncology, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.